NCT04084301View on ClinicalTrials.gov

Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 27, 2019

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2023

Conditions
Extracorporeal Circulation; ComplicationsRenal FailureCirculation DisorderRenal Plasma Flow, EffectiveCardiopulmonary BypassHemolysisInflammatory Response
Interventions
PROCEDURE

High CPB flow

Target CPB flow 2.9 L/min/m2 throughout the CPB period

Trial Locations (1)

416 53

Lukas Lannemyr, Gothenburg

All Listed Sponsors
lead

Sahlgrenska University Hospital

OTHER

NCT04084301 - Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury | Biotech Hunter | Biotech Hunter